Raymond James Financial Inc Royalty Pharma PLC Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Raymond James Financial Inc holds 783,633 shares of RPRX stock, worth $24.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
783,633Holding current value
$24.6 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
415Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.29 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$1.18 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$723 Million0.01% of portfolio
-
Baillie Gifford & CO14.1MShares$444 Million0.28% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$382 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $13.7B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...